Table 1.
Human genetic diseases associated with mutations in basement membrane constituents
Gene | Mutation type | Mutation effects | Disease | References |
---|---|---|---|---|
| ||||
LAMA2 | Substitutions, deletions, duplications, insertions, and inversions resulting in protein substitutions, deletions, frame shifts, nonsense, and complex variant Lmα2 chains. |
|
|
[17] |
| ||||
LAMA3 LAMB3 LAMC2 |
Frame shift, nonsense and missense mutations |
|
Junctional epidermolysis bullosa (JEB):
|
[19] |
| ||||
LAMB2 | Nonsense, missense, spice site mutations, multiple sites. Missense mutations clustered in LN domain. |
|
Pierson syndrome. Congenital nephrotic syndrome with eye abnormalities, microcoria. Muscular weakness/myasthenia may be present | [20] |
| ||||
COL4A1 | Frameshift | Disruption of the C-terminal NC1 domain | Hematuria, chronic kidney disease, renal cysts | [21] |
COL4A1 | G1236R G749S |
Amino acid change in the triple-helical domain | Porencephaly, hemorrhagic strokes | [22] |
COL4A1 | G1769A | Amino acid change in the triple-helical domain | Retinal hemorrhage, retinopathy | [23,24] |
COLA4A3 COL4A4 COL4A5 |
Splicing variants, missense mutations | Altered chain expression | Alport syndrome, deafness, lenticonus, cataract, maculopathy | [25,26] |
| ||||
COL6A1 | Gly missense mutations | Amino acid change in the triple helix | Ulrich congenital muscular dystrophy: severe hypotonia, early childhood Bethlehem myopathy: joint laxity and hypotonia |
[27] |
| ||||
COL7A1 | Amino acid mutations | Loss of α1 chain expression | Dystrophic epidermolysis bullosa | [28,29] |
| ||||
COL17A1 | Missense mutations | Exon truncation | Epithelial recurrent erosion dystrophy | [30,31] |
COL17A1 | Nonsense mutation | Premature stop codons | Junctional epidermolysis bullosa | [32] |
| ||||
COL18A1 | Frame-shift mutations nonsense mutations missense mutations | Altered chain reduction Loss of chain production |
Knobloch syndrome: high myopia, vitroretinal degeneration, occipital encephalocele, fasting triglyceridemia Duplication of kidney collecting system | [33–35] |
COL18A1 | Insertion, frame deletions splice site mutation | Change in the C-terminal chain | [36] | |
| ||||
HSPG2 | Duplicated exon 34 and frameshifts | Functionally null | Dyssegmental dysplasia, Silver-Handmaker type due to altered FGF2 signaling leading to aberrant cartilage architecture | [37–39] |
| ||||
HSPG2 | Missense and errors in alternative splicing | Truncated or ablated Domain V (endorepellin) | Schwartz-Jampel syndrome originating from disrupted neuromuscular junction arrangement and function | [38,40] |
| ||||
AGRN | Missense and nonsense mutations at the N-terminus and LG2 domain | Failure of neuromuscular transmission, pre- and post- synaptic | Congenital myasthenic syndrome, easy fatigability and muscle weakness | [41,42] |